æ°åã³ãããŠã€ã«ã¹ã«é¢ããæ å ±ã¯ãåçåŽåçã®æ å ±çºä¿¡ãµã€ããåèã«ããŠãã ãããæ å ±ãèŠã
ãšã³ããªãŒã®ç·šé
ãšã³ããªãŒã®ç·šéã¯å
šãŠãŒã¶ãŒã«å
±éã®æ©èœã§ãã
å¿
ãã¬ã€ãã©ã€ã³ãäžèªã®äžãå©çšãã ããã
ãã®ããŒãžã®ãªãŒããŒãªã®ã§ä»¥äžã®ã¢ã¯ã·ã§ã³ãå®è¡ã§ããŸã
åååŸããããšãã§ããŸã
倧接ç§äžðå»åž«ðç·©åã±ã¢å ç§ðæ©æããã®ç·©åã±ã¢å€æ¥ðé¢é·ðãã©ãã§ãç·©å®ãã§å šåœå¯Ÿå¿å¯ on X: "ã€ã³ãã¯ãããæ°çµæ(Clinical Infectious Diseases) æ°åã³ããææã§ã®ãŠã€ã«ã¹éã®ããŒã¯ãšæåæ€æ» 22幎4æ-23幎4ææœè¡ ã»ãŠã€ã«ã¹éã®äžå€®å€ã¯çºçæ¥ããäžæãã4/5æ¥ç®ã«ããŒã¯ã ã»æåæ€æ»ã®æ床ãçºç1æ¥ç®ã¯30-60%ã4æ¥ç®ã§80-93.3% çºçæã«ãŠã€ã«ã¹éãé«ãã£ã以åãšç°ãªããšææ"
ã¯ãŠãªããã¯ããŒã¯ã§
é¢å¿ãã·ã§ã¢ããã
ã¿ããªã®èå³ãšææ³ãéãŸãããšã§
æ°ããçºèŠããæ·±å ãããã£ãšæ¥œãã
ã¢ã«ãŠã³ãããæã¡ã®æ¹ã¯ãã°ã€ã³ããŒãžãž
èšäºãžã®ã³ã¡ã³ã2件
- 泚ç®ã³ã¡ã³ã
- æ°çã³ã¡ã³ã
泚ç®ã³ã¡ã³ãç®åºã¢ã«ãŽãªãºã ã®äžéšã«LINEã€ããŒæ ªåŒäŒç€Ÿã®ã建èšçã³ã¡ã³ãé äœä»ãã¢ãã«APIãã䜿çšããŠããŸã
- ãããŒåºåãªã
- ãã¥ãŒãæ©èœãã
- ããŒã¯ã¢ãŒãæèŒ
é¢é£èšäº
倧接ç§äžðå»åž«ðç·©åã±ã¢å ç§ðæ©æããã®ç·©åã±ã¢å€æ¥ðé¢é·ðãã©ãã§ãç·©å®ãã§å šåœå¯Ÿå¿å¯ on X: "ã€ã³ãã¯ãããæ°çµæ(Clinical Infectious Diseases) æ°åã³ããææã§ã®ãŠã€ã«ã¹éã®ããŒã¯ãšæåæ€æ» 22幎4æ-23幎4ææœè¡ ã»ãŠã€ã«ã¹éã®äžå€®å€ã¯çºçæ¥ããäžæãã4/5æ¥ç®ã«ããŒã¯ã ã»æåæ€æ»ã®æ床ãçºç1æ¥ç®ã¯30-60%ã4æ¥ç®ã§80-93.3% çºçæã«ãŠã€ã«ã¹éãé«ãã£ã以åãšç°ãªããšææ"
2023/09/30 ãªã³ã¯